<div id="readability-page-1">CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best short squeeze stocks to buy right now. Citizens reaffirmed its Market Outperform rating and $86 price target for CRISPR Therapeutics AG (NASDAQ:CRSP) on November 11. The firm discussed positive findings from CRISPR’s American Heart Association presentation on CTX310, targeted at ANGPTL3 for a variety of cholesterol issues. […]</div>

CRISPR治疗

<p>Citizens 重申了对 CRISPR Therapeutics AG 的市场优于大盘评级，并将其目标价格定为 86 美元，理由是尽管 Casgevy 的增长放缓，但 CRISPR 在美国心脏协会会议上关于 CTX310 的展示结果积极</p>

尽管 Casgevy 的增长放缓，Citizens 仍维持对 CRISPR Therapeutics（CRSP）的市场表现优于大盘的评级